Drug-induced hypothermia shows therapeutic potential for acute ischemic stroke in animal models and early human trial
By
Di Wu
Summary
This article presents research on drug-induced hypothermia as a potential treatment for acute ischemic stroke. The study demonstrates that chlorpromazine combined with promethazine (C+P) successfully induced hypothermia and showed therapeutic effects in both mouse and nonhuman primate models of ischemic stroke. A phase 1 dose-escalation trial in humans found that all tested doses of C+P were well tolerated, with the highest dose suppressing plasma proteomic markers of systemic aerobic metabolism. The findings support further investigation into this therapeutic approach for stroke treatment.
Source

Key quotes
· 5 pulledDrug-induced hypothermia can protect the mouse brain against hypoxic injury
chlorpromazine combined with promethazine (C+P) induced hypothermia and had therapeutic effects in a mouse model and a nonhuman primate model of ischemic stroke
all used doses of C+P were well tolerated and the highest dose suppressed plasma proteomic markers of systemic aerobic metabolism
These findings support further
Induction of a hypothermic and hypometabolic state is considered an avenue to treat...
You might also wanna read
Freezing brain damage in its tracks: cooling drugs limit stroke injury in mice
HKUMed develops world-first NanoPowder nasal spray for prehospital ischemic stroke treatment
A research team from HKUMed and InnoHK ABIC has developed the world's first 'NanoPowder nasal spray' for ischemic stroke. This innovation ov
UCLA discovers first stroke rehabilitation drug to repair brain damage

Scientists Develop Stroke Treatment by Enhancing Brain's Natural Waste Removal System
Scientists from Monash University and Yale School of Medicine are collaborating to develop a new treatment approach for ischemic stroke by e
Anti-aging drug combo dasatinib+quercetin causes brain damage in mice, study finds
A study from the University of Connecticut published in PNAS found that the dasatinib+quercetin (D+Q) drug combination, widely studied for a

Iloprost therapy reduces amputation risk in severe frostbite: Canadian retrospective cohort study
This retrospective cohort study evaluated iloprost therapy versus non-iloprost treatment for severe frostbite across two Canadian cities (Ca

Comments
Sign in to join the conversation.
No comments yet. Be the first.